These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Kjeldsen SE, Julius S. Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303 [Abstract] [Full Text] [Related]
3. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors. Wright JM. CMAJ; 2000 Aug 08; 163(3):293-6. PubMed ID: 10951729 [Abstract] [Full Text] [Related]
4. [Angiotensin converting enzyme inhibitors for hypertension]. Kobusiak-Prokopowicz M. Pol Merkur Lekarski; 1997 Jan 08; 2(7):66-70. PubMed ID: 9296907 [Abstract] [Full Text] [Related]
5. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure]. Andersen RS, Christensen S. Ugeskr Laeger; 2001 Dec 10; 163(50):7036-9. PubMed ID: 11794033 [Abstract] [Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep 10; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct 10; 14(79):180-6. PubMed ID: 16285075 [Abstract] [Full Text] [Related]
9. Age-related effects of angiotensin converting enzyme inhibitors. Breckenridge A. J Cardiovasc Pharmacol; 1988 Oct 10; 12 Suppl 8():S100-4. PubMed ID: 2469889 [Abstract] [Full Text] [Related]
10. [Is there a need for direct renin inhibitors?]. Grossman E. Harefuah; 2008 Mar 10; 147(3):216-7, 278. PubMed ID: 18488862 [Abstract] [Full Text] [Related]
11. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension. Prichard BN, Saul PA. J Cardiovasc Pharmacol; 1990 Mar 10; 16 Suppl 5():S81-5. PubMed ID: 11527141 [Abstract] [Full Text] [Related]
12. Hypertension in elderly--an overview. Bhattacharyya A, Das P. J Indian Med Assoc; 1999 Mar 10; 97(3):96-101. PubMed ID: 10652909 [Abstract] [Full Text] [Related]
14. [The use of angiotensin converting enzyme inhibitors in practice]. Zschiedrich H. Arzneimittelforschung; 1993 Feb 10; 43(2A):271-3. PubMed ID: 8498977 [Abstract] [Full Text] [Related]
15. RAS inhibition in hypertension. Ibrahim MM. J Hum Hypertens; 2006 Feb 10; 20(2):101-8. PubMed ID: 16397519 [Abstract] [Full Text] [Related]
16. [Are all antihypertensive drugs renoprotective?]. Wolf S, Risler T. Herz; 2004 May 10; 29(3):248-54. PubMed ID: 15167950 [Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion. Bubbar CD, Blackburn DF, Wilson MP, Wilson TW. Ann Pharmacother; 2007 Jan 10; 41(1):129-32. PubMed ID: 17179189 [Abstract] [Full Text] [Related]
18. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us. Frishman WH. Heart Dis; 2000 Jan 10; 2(5):384-8. PubMed ID: 11728287 [Abstract] [Full Text] [Related]
19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr 10; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]